Valuation Black Diamond Therapeutics, Inc. OTC Markets
Stocks
BDTX
US09203E1055
Biotechnology & Medical Research
|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
Company Valuation: Black Diamond Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 193.1 | 65.46 | 145.1 | 121.1 | 138.4 | 111.5 | - | - |
| Change | - | -66.1% | 121.66% | -16.54% | 14.33% | -19.49% | - | - |
| Enterprise Value (EV) | -16.69 | -57.35 | 145.1 | 121.1 | 138.4 | 111.5 | 111.5 | 111.5 |
| Change | - | -243.68% | 353.01% | -16.54% | 14.33% | -19.49% | 0% | 0% |
| P/E | -1.54x | -0.71x | -1.49x | -1.69x | 6.23x | -3.15x | -2.04x | -2.1x |
| PBR | 0.98x | - | - | - | - | - | - | - |
| PEG | - | 0x | 0.1x | 0.1x | -0x | 0x | -0x | 0.75x |
| Capitalization / Revenue | - | - | - | - | 1.98x | 17.8x | - | - |
| EV / Revenue | - | - | - | - | 0x | 17.8x | - | - |
| EV / EBITDA | 0x | 0x | - | -0x | 0x | -2.3x | -1.68x | -1.36x |
| EV / EBIT | 0x | 0x | -0x | -0x | 0x | -2.58x | -1.61x | -1.21x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.47 | -2.52 | -1.88 | -1.27 | 0.39 | -0.6162 | -0.9525 | -0.9257 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 70 | 6.25 | - | - |
| EBITDA 1 | -126.7 | -92.32 | - | -78.44 | 20.2 | -48.52 | -66.52 | -81.66 |
| EBIT 1 | -126.9 | -92.83 | -86.46 | -78.78 | 19.87 | -43.14 | -69.02 | -91.83 |
| Net income 1 | -125.6 | -91.17 | -82.44 | -69.68 | 22.37 | -36.96 | -64.65 | -87.39 |
| Net Debt | -209.8 | -122.8 | - | - | - | - | - | - |
| Reference price 2 | 5.330 | 1.800 | 2.810 | 2.140 | 2.430 | 1.940 | 1.940 | 1.940 |
| Nbr of stocks (in thousands) | 36,229 | 36,366 | 51,635 | 56,585 | 56,975 | 57,454 | - | - |
| Announcement Date | 3/17/22 | 3/9/23 | 3/12/24 | 3/6/25 | 3/16/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.73x | 7.72x | 15.51x | 1.37% | 74.31B | |
| 29.59x | 8.5x | 26.48x | 0.04% | 56.95B | |
| 33.52x | 6.02x | 18.04x | 0.97% | 48.3B | |
| -21.51x | 223.61x | -23.09x | -.--% | 44.51B | |
| 34.27x | 3.31x | 14.29x | -.--% | 43.8B | |
| 47.24x | 5.47x | 29.99x | -.--% | 41.12B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 31.07B | |
| 33.5x | 7.16x | 18.6x | -.--% | 28.97B | |
| -15.28x | 5.82x | -7.31x | -.--% | 24.53B | |
| Average | 21.19x | 30.62x | 12.55x | 0.31% | 43.73B | |
| Weighted average by Cap. | 22.51x | 31.17x | 13.62x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BDTX Stock
- BDTX Stock
- Valuation Black Diamond Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
